Omalizumab and Mepolizumab in the Landscape of Biological Therapy for Severe Asthma in Children: How to Choose?
Italian Journal of Pediatrics - United Kingdom
doi 10.1186/s13052-019-0737-4
Full Text
Open PDFAbstract
Available in full text
Date
November 28, 2019
Authors
Publisher
Springer Science and Business Media LLC